20
Participants
Start Date
June 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
DL6049 (injectable poly-L-lactic acid)
Subjects will be treated with SCULPTRA® every 4-6 weeks in accordance with SCULPTRA® package insert
London
Bausch Health Americas, Inc.
INDUSTRY